Antitumour effect and symptomatic control with interferon α2b in patients with endocrine active tumours
- 31 December 1992
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (10) , 1664-1666
- https://doi.org/10.1016/0959-8049(92)90064-9
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Interferon-α2b in Patients with Endocrine Active TumorsPublished by Springer Nature ,1990
- Interferon Treatment of Neuroendocrine Gut and Pancreatic TumorsPublished by Springer Nature ,1990
- INTERFERONSThe Lancet, 1989
- Interferon Treatment in Patients with Malignant CarcinoidsActa Oncologica, 1989
- Chemotherapy of metastatic carcinoid and islet cell tumors: A reviewThe American Journal of Medicine, 1987
- Zur Behandlung des metastasierten Karzinoids von Ileum und Caecum mit rekombinantem Interferon alpha-2bOncology Research and Treatment, 1987
- Long-Term Treatment of Patients with Endocrine Gastrointestinal Tumours with the Somatostatin Analogue SMS 201-995Scandinavian Journal of Gastroenterology, 1986
- Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemiaThe American Journal of Medicine, 1958